{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T16:05:14Z","timestamp":1783008314267,"version":"3.54.5"},"reference-count":84,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T00:00:00Z","timestamp":1524700800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["4855"],"award-info":[{"award-number":["4855"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0196400","type":"journal-article","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T13:27:48Z","timestamp":1524749268000},"page":"e0196400","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Megakaryocyte lineage development is controlled by modulation of protein acetylation"],"prefix":"10.1371","volume":"13","author":[{"given":"Marije","family":"Bartels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Govers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roel","family":"Polak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephin","family":"Vervoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"van Boxtel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelieke","family":"Pals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Bierings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter","family":"van Solinge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toine","family":"Egberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Nieuwenhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Mokry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8332-6828","authenticated-orcid":true,"given":"Paul James","family":"Coffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,4,26]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.devcel.2004.11.014","article-title":"Interplay of pu.1 and gata1 determines myelo-erythroid progenitor cell fate in zebrafish","volume":"8","author":"J Rhodes","year":"2005","journal-title":"Developmental cell"},{"issue":"15","key":"ref2","doi-asserted-by":"crossref","first-page":"8705","DOI":"10.1073\/pnas.96.15.8705","article-title":"Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1","volume":"96","author":"P Zhang","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"ref3","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1101\/gad.13.11.1398","article-title":"Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells","volume":"13","author":"N Rekhtman","year":"1999","journal-title":"Genes & development"},{"issue":"9","key":"ref4","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1182\/blood.V94.9.3037","article-title":"Pathophysiology of thrombocytopenia and anemia in mice lacking transcription factor NF-E2","volume":"94","author":"J Levin","year":"1999","journal-title":"Blood"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.devcel.2011.04.008","article-title":"Genome-wide analysis of simultaneous GATA1\/2, RUNX1, FLI1, and SCL binding in megakaryocytes identifies hematopoietic regulators","volume":"20","author":"MR Tijssen","year":"2011","journal-title":"Dev Cell"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1634\/stemcells.19-5-397","article-title":"Molecular and transcriptional regulation of megakaryocyte differentiation","volume":"19","author":"RA Shivdasani","year":"2001","journal-title":"Stem Cells"},{"issue":"47","key":"ref7","doi-asserted-by":"crossref","first-page":"6795","DOI":"10.1038\/sj.onc.1210762","article-title":"Transcriptional control of megakaryocyte development","volume":"26","author":"AN Goldfarb","year":"2007","journal-title":"Oncogene"},{"issue":"24","key":"ref8","doi-asserted-by":"crossref","first-page":"18909","DOI":"10.1074\/jbc.M110.102145","article-title":"New roles for cyclin E in megakaryocytic polyploidization","volume":"285","author":"A Eliades","year":"2010","journal-title":"The Journal of biological chemistry"},{"issue":"13","key":"ref9","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1182\/blood-2010-01-265785","article-title":"Aurora B is dispensable for megakaryocyte polyploidization, but contributes to the endomitotic process","volume":"116","author":"L Lordier","year":"2010","journal-title":"Blood"},{"issue":"8","key":"ref10","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1182\/blood-2008-03-144956","article-title":"Megakaryocyte endomitosis is a failure of late cytokinesis related to defects in the contractile ring and Rho\/Rock signaling","volume":"112","author":"L Lordier","year":"2008","journal-title":"Blood"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1182\/blood-2008-11-190801","article-title":"Survivin is not required for the endomitotic cell cycle of megakaryocytes","volume":"114","author":"Q Wen","year":"2009","journal-title":"Blood"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/ng1531","article-title":"Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer","volume":"37","author":"MF Fraga","year":"2005","journal-title":"Nature genetics"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.4161\/cc.4.10.2113","article-title":"Towards the human cancer epigenome: a first draft of histone modifications","volume":"4","author":"MF Fraga","year":"2005","journal-title":"Cell Cycle"},{"issue":"9","key":"ref14","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0960-9822(06)00296-X","article-title":"Acetylation of general transcription factors by histone acetyltransferases","volume":"7","author":"A Imhof","year":"1997","journal-title":"Current biology: CB"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.leukres.2009.07.019","article-title":"Epigenetic modifications in AML and MDS","volume":"34","author":"M Mahmud","year":"2010","journal-title":"Leukemia research"},{"issue":"47","key":"ref16","doi-asserted-by":"crossref","first-page":"6697","DOI":"10.1038\/sj.onc.1210755","article-title":"Epigenetic regulation of normal and malignant hematopoiesis","volume":"26","author":"KL Rice","year":"2007","journal-title":"Oncogene"},{"issue":"18","key":"ref17","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1517\/14656566.2010.534779","article-title":"Emerging role of the histone deacetylase inhibitor romidepsin in hematologic malignancies","volume":"11","author":"N Jain","year":"2010","journal-title":"Expert opinion on pharmacotherapy"},{"issue":"9","key":"ref18","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1517\/13543784.2013.815165","article-title":"Panobinostat in lymphoid and myeloid malignancies","volume":"22","author":"A Khot","year":"2013","journal-title":"Expert opinion on investigational drugs"},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2174\/138955711795843347","article-title":"Histone deacetylase inhibitors in the treatment of hematological malignancies","volume":"11","author":"A Petrella","year":"2011","journal-title":"Mini reviews in medicinal chemistry"},{"issue":"18","key":"ref20","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1200\/JCO.2011.38.3265","article-title":"Phase II trial of vorinostat with idarubicin and cytarabine for patients with newly diagnosed acute myelogenous leukemia or myelodysplastic syndrome","volume":"30","author":"G Garcia-Manero","year":"2012","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.canlet.2012.07.030","article-title":"Synergistic effect of panobinostat and bortezomib on chemoresistant acute myelogenous leukemia cells via AKT and NF-kappaB pathways","volume":"326","author":"XJ Jiang","year":"2012","journal-title":"Cancer Lett"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s13148-011-0031-9","article-title":"Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acid","volume":"2","author":"A Kuendgen","year":"2011","journal-title":"Clin Epigenetics"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1038\/bcj.2012.14","article-title":"The oral HDAC inhibitor pracinostat (SB939) is efficacious and synergistic with the JAK2 inhibitor pacritinib (SB1518) in preclinical models of AML","volume":"2","author":"V Novotny-Diermayr","year":"2012","journal-title":"Blood Cancer J"},{"issue":"11","key":"ref24","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1007\/s00277-017-3103-x","article-title":"Encouraging results with the compassionate use of hydralazine\/valproate (TRANSKRIP) as epigenetic treatment for myelodysplastic syndrome (MDS)","volume":"96","author":"M Candelaria","year":"2017","journal-title":"Ann Hematol"},{"issue":"31","key":"ref25","doi-asserted-by":"crossref","first-page":"51429","DOI":"10.18632\/oncotarget.18009","article-title":"Decitabine-Vorinostat combination treatment in acute myeloid leukemia activates pathways with potential for novel triple therapy","volume":"8","author":"CS Young","year":"2017","journal-title":"Oncotarget"},{"issue":"7","key":"ref26","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/pbc.24152","article-title":"Valproic acid synergistically enhances the cytotoxicity of clofarabine in pediatric acute myeloid leukemia cells","volume":"59","author":"C Xie","year":"2012","journal-title":"Pediatric blood & cancer"},{"issue":"17","key":"ref27","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.4161\/cc.21565","article-title":"Deacetylase inhibitors modulate proliferation and self-renewal properties of leukemic stem and progenitor cells","volume":"11","author":"A Romanski","year":"2012","journal-title":"Cell Cycle"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1182\/blood-2007-06-098061","article-title":"Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes","volume":"111","author":"G Garcia-Manero","year":"2008","journal-title":"Blood"},{"issue":"Suppl 1","key":"ref29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00277-005-0026-8","article-title":"Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia","volume":"84","author":"A Kuendgen","year":"2005","journal-title":"Ann Hematol"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/cncr.21552","article-title":"The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all-trans retinoic acid in patients with acute myeloid leukemia","volume":"106","author":"A Kuendgen","year":"2006","journal-title":"Cancer"},{"issue":"12","key":"ref31","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1002\/cncr.21589","article-title":"Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia","volume":"104","author":"G Bug","year":"2005","journal-title":"Cancer"},{"issue":"7","key":"ref32","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3324\/haematol.2009.008870","article-title":"Histone deacetylase inhibition modulates cell fate decisions during myeloid differentiation","volume":"95","author":"M Bartels","year":"2010","journal-title":"Haematologica"},{"issue":"7","key":"ref33","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1158\/0008-5472.CAN-04-3011","article-title":"Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells","volume":"65","author":"G Bug","year":"2005","journal-title":"Cancer research"},{"issue":"13","key":"ref34","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1182\/blood-2011-08-375386","article-title":"The combination of valproic acid and lithium delays hematopoietic stem\/progenitor cell differentiation","volume":"119","author":"MA Walasek","year":"2012","journal-title":"Blood"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1158\/0008-5472.CAN-04-3063","article-title":"Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells","volume":"65","author":"L De Felice","year":"2005","journal-title":"Cancer research"},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.bcp.2010.11.011","article-title":"Valproic acid perturbs hematopoietic homeostasis by inhibition of erythroid differentiation and activation of the myelo-monocytic pathway","volume":"81","author":"S Chateauvieux","year":"2011","journal-title":"Biochemical pharmacology"},{"issue":"8","key":"ref37","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.exphem.2010.03.019","article-title":"A potential activity of valproic acid in the stimulation of interleukin-3-mediated megakaryopoiesis and erythropoiesis","volume":"38","author":"B Liu","year":"2010","journal-title":"Experimental hematology"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00043426-200001000-00012","article-title":"Hematologic toxicity of sodium valproate","volume":"22","author":"S Acharya","year":"2000","journal-title":"J Pediatr Hematol Oncol"},{"issue":"6","key":"ref39","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/j.1528-1157.1993.tb02139.x","article-title":"Hematologic manifestations of long-term valproate therapy","volume":"34","author":"RB May","year":"1993","journal-title":"Epilepsia"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1528-1167.2007.01429.x","article-title":"Valproate-induced thrombocytopenia: a prospective monotherapy study","volume":"49","author":"W Nasreddine","year":"2008","journal-title":"Epilepsia"},{"issue":"3","key":"ref41","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/JCP.0b013e3181db2684","article-title":"Hematological effects of valproate in psychiatric patients: what are the risk factors?","volume":"30","author":"K Vasudev","year":"2010","journal-title":"Journal of clinical psychopharmacology"},{"issue":"4","key":"ref42","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1365-2141.2006.06341.x","article-title":"Nicotinamide (vitamin B3) increases the polyploidisation and proplatelet formation of cultured primary human megakaryocytes","volume":"135","author":"LM Giammona","year":"2006","journal-title":"British Journal of Haematology"},{"issue":"11","key":"ref43","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.exphem.2009.08.004","article-title":"Mechanistic studies on the effects of nicotinamide on megakaryocytic polyploidization and the roles of NAD+ levels and SIRT inhibition","volume":"37","author":"LM Giammona","year":"2009","journal-title":"Experimental hematology"},{"issue":"1","key":"ref44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/1354750X.2010.526243","article-title":"Discriminative value of platelet size indices for the identification of the mechanism of chemotherapy-induced thrombocytopenia","volume":"16","author":"MJ ten Berg","year":"2011","journal-title":"Biomarkers: biochemical indicators of exposure, response, and susceptibility to chemicals"},{"issue":"6","key":"ref45","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/JCP.0b013e318270e5e2","article-title":"Valproic acid treatment is associated with altered leukocyte subset development","volume":"32","author":"M Bartels","year":"2012","journal-title":"Journal of clinical psychopharmacology"},{"issue":"18","key":"ref46","doi-asserted-by":"crossref","first-page":"11872","DOI":"10.1073\/pnas.172384399","article-title":"Prospective isolation of human clonogenic common myeloid progenitors","volume":"99","author":"MG Manz","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"9","key":"ref47","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/cdd.2013.81","article-title":"FOXP1 acts through a negative feedback loop to suppress FOXO-induced apoptosis","volume":"20","author":"R van Boxtel","year":"2013","journal-title":"Cell death and differentiation"},{"issue":"14","key":"ref48","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"H Li","year":"2009","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"11","key":"ref49","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/nbt.1505","article-title":"An integrated software system for analyzing ChIP-chip and ChIP-seq data","volume":"26","author":"H Ji","year":"2008","journal-title":"Nature biotechnology"},{"issue":"9","key":"ref50","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.yexcr.2006.01.017","article-title":"HDAC inhibition is associated to valproic acid induction of early megakaryocytic markers","volume":"312","author":"F Vulcano","year":"2006","journal-title":"Experimental cell research"},{"issue":"7","key":"ref51","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3324\/haematol.2009.008870","article-title":"Histone deacetylase inhibition modulates cell fate decisions during myeloid differentiation","volume":"95","author":"M Bartels","year":"2010","journal-title":"Haematologica"},{"issue":"8","key":"ref52","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1111\/j.1538-7836.2011.04396.x","article-title":"c-Myb and GATA-1 alternate dominant roles during megakaryocyte differentiation","volume":"9","author":"P Garcia","year":"2011","journal-title":"Journal of thrombosis and haemostasis: JTH"},{"issue":"2","key":"ref53","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.devcel.2004.12.015","article-title":"c-Myb and p300 regulate hematopoietic stem cell proliferation and differentiation","volume":"8","author":"ML Sandberg","year":"2005","journal-title":"Developmental cell"},{"issue":"6597","key":"ref54","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/383269a0","article-title":"Transcription-linked acetylation by Gcn5p of histones H3 and H4 at specific lysines","volume":"383","author":"MH Kuo","year":"1996","journal-title":"Nature"},{"issue":"4","key":"ref55","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1517\/17425255.2013.754011","article-title":"Toxicological and metabolic considerations for histone deacetylase inhibitors","volume":"9","author":"J Fraczek","year":"2013","journal-title":"Expert opinion on drug metabolism & toxicology"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"e738","DOI":"10.1038\/cddis.2013.260","article-title":"Thrombocytopenia induced by the histone deacetylase inhibitor abexinostat involves p53-dependent and -independent mechanisms","volume":"4","author":"A Ali","year":"2013","journal-title":"Cell death & disease"},{"issue":"13","key":"ref57","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1182\/blood-2010-11-318055","article-title":"Deciphering the molecular and biologic processes that mediate histone deacetylase inhibitor-induced thrombocytopenia","volume":"117","author":"MJ Bishton","year":"2011","journal-title":"Blood"},{"issue":"24","key":"ref58","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"M Gottlicher","year":"2001","journal-title":"EMBO J"},{"issue":"13","key":"ref59","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1093\/emboj\/cdg315","article-title":"The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2","volume":"22","author":"OH Kramer","year":"2003","journal-title":"EMBO J"},{"issue":"10","key":"ref60","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1038\/sj.leu.2403910","article-title":"Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors","volume":"19","author":"CA Bradbury","year":"2005","journal-title":"Leukemia"},{"issue":"44","key":"ref61","doi-asserted-by":"crossref","first-page":"30673","DOI":"10.1074\/jbc.M109.042242","article-title":"Expression Levels of Histone Deacetylases Determine the Cell Fate of Hematopoietic Progenitors","volume":"284","author":"T Wada","year":"2009","journal-title":"Journal of Biological Chemistry"},{"issue":"15","key":"ref62","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1038\/emboj.2010.136","article-title":"Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesis","volume":"29","author":"RH Wilting","year":"2010","journal-title":"EMBO J"},{"issue":"Pt 3","key":"ref63","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1042\/bj20021321","article-title":"Histone deacetylases (HDACs): characterization of the classical HDAC family","volume":"370","author":"AJM de Ruijter","year":"2003","journal-title":"The Biochemical journal"},{"issue":"3","key":"ref64","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1074\/jbc.M110.115725","article-title":"Histone deacetylase 9 activates gamma-globin gene expression in primary erythroid cells","volume":"286","author":"SA Muralidhar","year":"2011","journal-title":"The Journal of biological chemistry"},{"issue":"1","key":"ref65","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/10428194.2011.597905","article-title":"Increased gene expression of histone deacetylases in patients with Philadelphia-negative chronic myeloproliferative neoplasms","volume":"53","author":"V Skov","year":"2012","journal-title":"Leukemia & lymphoma"},{"issue":"22","key":"ref66","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1182\/blood-2009-08-238311","article-title":"c-myb supports erythropoiesis through the transactivation of KLF1 and LMO2 expression","volume":"116","author":"E Bianchi","year":"2010","journal-title":"Blood"},{"issue":"8","key":"ref67","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0959-8049(03)00072-8","article-title":"Histone acetylation-mediated regulation of genes in leukaemic cells","volume":"39","author":"AE Chambers","year":"2003","journal-title":"Eur J Cancer"},{"issue":"18","key":"ref68","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1128\/MCB.00545-09","article-title":"HOXA9 Modulates Its Oncogenic Partner Meis1 To Influence Normal Hematopoiesis","volume":"29","author":"YL Hu","year":"2009","journal-title":"Molecular and cellular biology"},{"issue":"12","key":"ref69","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1182\/blood-2005-07-2968","article-title":"Coordination of erythropoiesis by the transcription factor c-Myb","volume":"107","author":"A Vegiopoulos","year":"2006","journal-title":"Blood"},{"issue":"19","key":"ref70","doi-asserted-by":"crossref","first-page":"10794","DOI":"10.1073\/pnas.1934713100","article-title":"Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice","volume":"100","author":"HL Cheng","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7255","key":"ref71","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nature08197","article-title":"Recent progress in the biology and physiology of sirtuins","volume":"460","author":"T Finkel","year":"2009","journal-title":"Nature"},{"issue":"1","key":"ref72","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1128\/MCB.23.1.38-54.2003","article-title":"The mammalian SIR2alpha protein has a role in embryogenesis and gametogenesis","volume":"23","author":"MW McBurney","year":"2003","journal-title":"Mol Cell Biol"},{"issue":"5666","key":"ref73","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1126\/science.1094637","article-title":"Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase","volume":"303","author":"A Brunet","year":"2004","journal-title":"Science (New York, NY)"},{"issue":"2","key":"ref74","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0092-8674(01)00527-X","article-title":"hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase","volume":"107","author":"H Vaziri","year":"2001","journal-title":"Cell"},{"issue":"4","key":"ref75","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.cell.2005.01.029","article-title":"Calorie restriction\u2014the SIR2 connection","volume":"120","author":"L Guarente","year":"2005","journal-title":"Cell"},{"issue":"12","key":"ref76","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1172\/JCI26720","article-title":"Megakaryocyte biology and related disorders","volume":"115","author":"L Pang","year":"2005","journal-title":"The Journal of clinical investigation"},{"issue":"11","key":"ref77","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.exphem.2009.08.004","article-title":"Mechanistic studies on the effects of nicotinamide on megakaryocytic polyploidization and the roles of NAD+ levels and SIRT inhibition","volume":"37","author":"LM Giammona","year":"2009","journal-title":"Experimental hematology"},{"issue":"8","key":"ref78","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1634\/stemcells.2004-0171","article-title":"Transcriptional profiling of human hematopoiesis during in vitro lineage-specific differentiation","volume":"23","author":"M Komor","year":"2005","journal-title":"Stem Cells"},{"issue":"8","key":"ref79","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1182\/blood-2006-07-037838","article-title":"Interrelation between polyploidization and megakaryocyte differentiation: a gene profiling approach","volume":"109","author":"H Raslova","year":"2007","journal-title":"Blood"},{"issue":"3","key":"ref80","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1084\/jem.20111709","article-title":"Lethal myelofibrosis induced by Bmi1-deficient hematopoietic cells unveils a tumor suppressor function of the polycomb group genes","volume":"209","author":"H Oguro","year":"2012","journal-title":"The Journal of experimental medicine"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"e380","DOI":"10.1038\/cddis.2012.119","article-title":"Notch1 intracellular domain increases cytoplasmic EZH2 levels during early megakaryopoiesis","volume":"3","author":"A Roy","year":"2012","journal-title":"Cell death & disease"},{"issue":"12","key":"ref82","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1084\/jem.20131144","article-title":"Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders","volume":"210","author":"T Muto","year":"2013","journal-title":"The Journal of experimental medicine"},{"key":"ref83","article-title":"Polycomb Repressive Complex 2 Regulates Normal Hematopoietic Stem Cell Function in a Developmental-Stage-Specific Manner","author":"H Xie","year":"2013","journal-title":"Cell stem cell"},{"issue":"2","key":"ref84","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4161\/cc.7.2.5148","article-title":"PI3K\/Akt\/FOXO3a pathway contributes to thrombopoietin-induced proliferation of primary megakaryocytes in vitro and in vivo via modulation of p27(Kip1)","volume":"7","author":"T Nakao","year":"2008","journal-title":"Cell cycle (Georgetown, Tex)"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0196400","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T23:51:16Z","timestamp":1571269876000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0196400"}},"subtitle":[],"editor":[{"given":"Francesco","family":"Bertolini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,4,26]]},"references-count":84,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0196400","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,26]]}}}